Thus, the decrease in AMPKα2 targeted by let-7 might explain the early metabolic disorders in offspring and even the susceptibility to NAFLD in the future (Figure 1). The gene discussed is PRKAA2; the disease is metabolic dysfunction-associated steatotic liver disease.